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Brucella melitensis has been reported in limited cases of
rhythm device infection and has been described as being
insidious in its progression. In this report, we emphasize the
role of tissue and pocket-fluid extended cultures, espe-
cially in patients coming from brucella-endemic areas.
While tissue cultures may confirm diagnosis in these pa-
tients, they typically have negative blood and swab
cultures.i Mohammed Elmujtaba,
ince Sultan Cardiac Center,
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A 54-year-old female with long-standing idiopathic dilated
cardiomyopathy and a low ejection fraction underwent
implantation of Cardiac Resynchronization Therapy with a
Defibrillator (CRT-D) in 2007. A pulse generator replace-
ment was subsequently required in 2012. Two years later,
the patient began having intermittent febrile illness and
joint pain. She was thoroughly investigated without a final
conclusion in her local hospital, and her symptoms pro-
gressed insidiously. Two months prior to her current pre-
sentation, she noticed a papular lesion over the device area
with an intermittent purulent discharge. An initial evalua-
tion at our center showed clinical evidence of a device
pocket infection, and her inflammatory markers were high,
though multiple blood cultures were negative, Based on the
clinical presentation and the patient’s history of raw milk
ingestion, a Brucella device infection was suspected. The
Brucella agglutination titer was 1:20480, and the IgG Bru-
cella antibody titer was 1:1280. A trans-esophageal echo
showed large masses attached to all leads. A completeElsevier B.V. This is an open access article under the CC BY-NC-ND
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extraction system (Spectranetics, Colorado Springs, CO,
USA) and Lead Locking Device (LLD)(Fig. 1). Extended cul-
ture from the device pocket fluid and tissues showed
growth of Brucella melitnesis. The patient began an
extended antibiotic regimen and demonstrated excellent
clinical and serological improvement. A contralateral de-
vice re-implantation was scheduled three months after the
CRT-D System removal.
3. Case Two
A 52-year-old male with a long-standing history of diabetes
underwent coronary arteries bypass graft and mitral valve
repair in 2010. He received a single chamber ICD as a sec-
ondary prevention of sudden cardiac death in 2012. One
year later, he was diagnosed as having Brucellosis and
received appropriate treatment for eight weeks with an
excellent response. Two months prior to his current pre-
sentation, he noticed changes in the skin color over the
device site, which had gradually eroded resulting in device
extrusion (Fig. 2). His inflammatory markers were high, but
repeated blood cultures were negative, as was a swab from
the device site. He underwent a complete system removal,Figure 1 Laser extracted ventricular ICD lead showing a
small mass attached to the distal part of a heavily encapsu-
lated lead.
Figure 2 ICD pulse generator eroding throughout the skin.which was achieved by simple traction using an LLD.
Extended pocket tissue culture revealed growth of Brucella
mellitensis. He received an antibiotic combination regimen
for Brucella including Co-trimaxazole, Doxycycllinand, and
Gentamicin for an extended period. A contralateral ICD re-
implantation was scheduled for three months post-removal.
4. Discussion
Despite the improvement in procedural technique and
administration of antibiotic prophylaxis, device infections
continued to occur.1 Brucella melitensis has only been re-
ported in several cases of rhythm device infection and has
been described as being insidious in its progression.2e4 It is
possible that device infection might occur during the
asymptomatic phase of the illness as a result of the initial
bacteria micro phase; the bacteria colonize the device
collagen capsule and react as a permanent focus of infec-
tion, even after the standard regimen of treatment.5
Optimal management of infected devices should include
removal of the whole system and prolonged antimicrobial
therapy to eliminate the pathogen from the body, espe-
cially in the presence of an unusual organism.1 In all pre-
viously reported cases of Brucella infection, device removal
and leads extraction followed by extended antibiotic
therapy were required for its cure.2e4 In this report, we
emphasize the role of tissue and pocket-fluid extended
cultures, especially in patients coming from a brucella-
endemic area.6 In the past century, the introduction and
widespread application of sternal aspiration for studying
living bone marrow have given clinicians a simple and
practical method for studying and diagnosing diseases, such
as brucellosis.7 In our patients, repeated blood and swab
cultures were negative during all phases of infection, but
tissue cultures confirmed the diagnosis.
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